UB Paderborn / Katalog / Suche / in CDI

26 – 50 von 252

Sortiert nach

478P TA-ness classification discriminates RAS wild-type (wt) metastatic colorectal cancer (mCRC) patients (pts) who may benefit from antiEGFR treatment

Annals of oncology, 2021-09, Vol.32, p.S570-S570

2021

Link zum Volltext

Verfügbarkeit prüfen

1819P - Clinical practice evaluation of opioids induced constipation management in cancer patients: The EIO-Praxis project

Annals of oncology, 2019-10, Vol.30, p.v739-v739

2019

Link zum Volltext

Verfügbarkeit prüfen

Clinical practice evaluation of opioids induced constipation management in cancer patients: The EIO-Praxis project

Annals of oncology, 2019-10, Vol.30, p.v739

2019

Link zum Volltext

Verfügbarkeit prüfen

53P Oral metronomic-continuous cyclophosphamide (MCy) for elderly or unfit patients with advanced soft tissue sarcoma (STS): Reina Sofía University Hospital experience

ESMO open, 2023-03, Vol.8 (1), p.101090, Article 101090

2023

Link zum Volltext

Verfügbarkeit prüfen

Integrative multi-platform meta-analysis of gene expression profiles in pancreatic ductal adenocarcinoma patients for identifying novel diagnostic biomarkers

Annals of oncology, 2017-09, Vol.28, p.v451-v451

2017

Link zum Volltext

Verfügbarkeit prüfen

575P - RAS mutant allele fraction in plasma predicts benefit to anti-angiogenic based first-line treatment in metastatic colorectal cancer

Annals of oncology, 2019-10, Vol.30, p.v217-v217

2019

Link zum Volltext

Verfügbarkeit prüfen

RAS mutant allele fraction in plasma predicts benefit to anti-angiogenic based first-line treatment in metastatic colorectal cancer

Annals of oncology, 2019-10, Vol.30, p.v217

2019

Link zum Volltext

Verfügbarkeit prüfen

553P - Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (CC): Updated analysis of stage II disease from the AVANT phase III randomized trial by the GERCOR group

Annals of oncology, 2019-10, Vol.30, p.v209-v209

2019

Link zum Volltext

Verfügbarkeit prüfen

ULTRA clinical trial: Prospective comparative clinical outcome analysis of three different RAS/BRAF sensitivity mutational cut-offs. A Phase II study of the Spanish TTD Group

Annals of oncology, 2017-09, Vol.28, p.v185-v186

2017

Link zum Volltext

Verfügbarkeit prüfen

Circulating tumor (ct) DNA captures intrapatient heterogeneity in metastatic colorectal (mCRC) patients (pts) progressing to FOLFIRI+panitumumab

Annals of oncology, 2017-09, Vol.28, p.v183-v184

2017

Link zum Volltext

Verfügbarkeit prüfen

First prospective multicenter real-world RAS mutation comparison between OncoBEAM-based liquid biopsy and tissue analysis

Annals of oncology, 2017-09, Vol.28, p.v36-v36

2017

Link zum Volltext

Verfügbarkeit prüfen

C?ncer de est?mago

Medicine - programa de formación médica continuada acreditado, 2005-02, Vol.9 (25), p.1613-1620

2005

Link zum Volltext

Verfügbarkeit prüfen

C?ncer de colon

Medicine - programa de formación médica continuada acreditado, 2005-02, Vol.9 (25), p.1621-1627

2005

Link zum Volltext

Verfügbarkeit prüfen

C?ncer de es?fago

Medicine - programa de formación médica continuada acreditado, 2005-02, Vol.9 (25), p.1605-1612

2005

Link zum Volltext

Verfügbarkeit prüfen

Benefits of upfront primary tumour resection (UPTR) according to sidedness in mCRC: Retrospective analyses of TTD MACRO-2 and PLANET randomised trials

Annals of oncology, 2017-09, Vol.28, p.v167-v167

2017

Link zum Volltext

Verfügbarkeit prüfen

Cáncer de esófago

Medicine - programa de formación médica continuada acreditado, 2005, Vol.9 (25), p.1605-1612

2005

Link zum Volltext

Verfügbarkeit prüfen

Cáncer de estómago

Medicine - programa de formación médica continuada acreditado, 2005, Vol.9 (25), p.1613-1620

2005

Link zum Volltext

Verfügbarkeit prüfen

Cáncer de colon

Medicine - programa de formación médica continuada acreditado, 2005, Vol.9 (25), p.1621-1627

2005

Link zum Volltext

Verfügbarkeit prüfen

26 – 50 von 252

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(225)
Mit Volltextzugriff
(226)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(77)
Life Sciences & Biomedicine
(46)
Humans
(40)
Physics
(30)
Female
(26)
Physical Sciences
(25)
Elementary Particles
(19)
Male
(18)
Physics And Astronomy
(18)
Quantum Field Theories
(18)
Quantum Field Theory
(18)
String Theory
(18)
Aged
(17)
Physics, Particles & Fields
(17)
Large Hadron Collider
(16)
Regular Article - Experimental Physics
(16)
Astronomy
(13)
Astrophysics And Cosmology
(13)
Hadrons
(13)
Heavy Ions
(13)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

455P Concordance of baseline RAS mutational status (ms) between tissue and cell-free DNA (cfDNA) and association with overall response rate (ORR) in first-line (1L) metastatic colorectal cancer (mCRC) patients (pts): PERSEIDA study (cohort 2) (NCT02792478)

478P TA-ness classification discriminates RAS wild-type (wt) metastatic colorectal cancer (mCRC) patients (pts) who may benefit from antiEGFR treatment

1819P - Clinical practice evaluation of opioids induced constipation management in cancer patients: The EIO-Praxis project

Clinical practice evaluation of opioids induced constipation management in cancer patients: The EIO-Praxis project

53P Oral metronomic-continuous cyclophosphamide (MCy) for elderly or unfit patients with advanced soft tissue sarcoma (STS): Reina Sofía University Hospital experience

Integrative multi-platform meta-analysis of gene expression profiles in pancreatic ductal adenocarcinoma patients for identifying novel diagnostic biomarkers

585P - POLAF study: Efficacy and safety of FOLFIRI/aflibercept in a phase II trial in patients with metastatic colorectal cancer: Results of plasmatic prognostic and predictive markers

POLAF study: Efficacy and safety of FOLFIRI/aflibercept in a phase II trial in patients with metastatic colorectal cancer: Results of plasmatic prognostic and predictive markers

625P - Clinical relevance of circulating tumour (ct)DNA genotyping for first-line cetuximab-based treatment monitoring in metastatic colorectal cancer (mCRC): A prospective multicentric study

575P - RAS mutant allele fraction in plasma predicts benefit to anti-angiogenic based first-line treatment in metastatic colorectal cancer

Clinical relevance of circulating tumour (ct)DNA genotyping for first-line cetuximab-based treatment monitoring in metastatic colorectal cancer (mCRC): A prospective multicentric study

RAS mutant allele fraction in plasma predicts benefit to anti-angiogenic based first-line treatment in metastatic colorectal cancer

553P - Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (CC): Updated analysis of stage II disease from the AVANT phase III randomized trial by the GERCOR group

Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (CC): Updated analysis of stage II disease from the AVANT phase III randomized trial by the GERCOR group

ULTRA clinical trial: Prospective comparative clinical outcome analysis of three different RAS/BRAF sensitivity mutational cut-offs. A Phase II study of the Spanish TTD Group

Circulating tumor (ct) DNA captures intrapatient heterogeneity in metastatic colorectal (mCRC) patients (pts) progressing to FOLFIRI+panitumumab

First prospective multicenter real-world RAS mutation comparison between OncoBEAM-based liquid biopsy and tissue analysis

Phase II randomized trial of capecitabine + radiation therapy with/without bevacizumab as preoperative treatment for patients with resectable locally advanced rectal adenocarcinoma: Final results of 3 and 5-year disease free survival, distant relapse free survival and overall survival

C?ncer de est?mago

C?ncer de colon

C?ncer de es?fago

Benefits of upfront primary tumour resection (UPTR) according to sidedness in mCRC: Retrospective analyses of TTD MACRO-2 and PLANET randomised trials

Cáncer de esófago

Cáncer de estómago

Cáncer de colon

Suchergebnisse filtern